Amirabbas Rahimi, Morteza Karimipoor, Reza Mahdian, Atefeh Alipour, Saadi Hosseini, Marzieh Mohammadi, Hooman Kaghazian, Abdolrahim Abbasi, Hosein Shahsavarani, Mohammad Ali Shokrgozar
BACKGROUND: Despite recent advances in recombinant biotherapeutics production using CHO cells, their productivity remains lower than industrial needs, mainly due to apoptosis. OBJECTIVES: Present study aimed to exploit CRISPR/Cas9 technology to specifically disrupt the BAX gene to attenuate apoptosis in recombinant Chinese hamster's ovary cells producing erythropoietin. MATERIALS AND METHODS: The STRING database was used to identify the key pro-apoptotic genes to be modified by CRISPR/Cas9 technique...
April 2023: Iranian Journal of Biotechnology